The FDA approved a label update for 2 versions of the Depo-Provera birth control injection to include the risk for meningioma.

FDA adds brain tumor warning to Depo-Provera label for Pfizer’s birth control injections after studies link the drug to meningioma risk.

FDA approves a new Depo-Provera warning on meningioma risk as Pfizer faces lawsuits alleging delayed disclosure of brain ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns ...

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DEPO-PROVERA contains the active ingredient medroxyprogesterone ...

The action follows mounting scientific evidence linking the injectable contraceptive medication to an increased risk for meningioma.

With thousands of lawsuits and growing concerns over long-term risks, the FDA have added a brain tumor warning to the drug's label.

On Monday US time, Pfizer will appear in federal court in Pensacola, Florida, for a crucial hearing on whether the case — which could have a potential claim value in the billions of dollars — can ...

Provera’s label to include a warning about meningioma, a type of brain tumour. The change follows studies and a lawsuit ...